Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is it conceivable that the “financing problem” is being handled by hopes of Chiesi milestone payments? Wouldn’t submitting their application to the FDA trigger a milestone. Did i misunderstand that happening around April/May time frame. And am i correct in my recollection we do not know the precise details of the size of the milestone payments?
I recall seeing as trials are enrolled clinical expenses should decrease which lessens cash burn. Also we don’t fully know how much they offset with Brazil sales. I think that was a few million. There is the potential for those to offset and cash runway to endure slightly longer. No?
Fact-checks are appreciated as I haven’t had the chance to dive deeper recently. Been following very loosely.
Intriguing interview with Dror at the bio symposium. Worth the watch. Interested in some of you more experienced folks’ opinion(s).
So there’s a rumor that Alberta is giving Aurora 350 million and the condition is T. Booth was to not be at the helm.....
Also unconfirmed rumours that Alberta is giving $ACB $350m and the one condition was that Terry Booth wasn’t to behind the wheel. #PotStocks
— Betting Bruiser (@BettingBruiser) February 6, 2020
Corporate Welfare Meet $ACB ... to clarify what is being rumoured to be true ...is the money will come from @atbfinancial which is Alberta’s Crown Corporation #PotStocks
— Betting Bruiser (@BettingBruiser) February 6, 2020
So we got Dror presenting in New York Monday (2/10) at the Bio CEO & Investor conference and “will be available to participate in one on one partnering meetings”. Dror presenting two Monday’s from now (2/17) at the Noble Capital Markets conference with same description.
Meanwhile the WORLD symposium is happening 2/10-2/13 and three principal investigators are presenting there.
Hopefully some news comes out or data update and we see some solid action.
Fingers crossed.
I agree 100%
For anyone wandering about the Germany halt:
Aurora Cannabis (ACB +4.5%) is up on below-average volume in reaction to European Union Good Manufacturing Practice (EU GMP) certification for its Bradford, Ontario production facility, a regulatory requirement for the export of medical cannabis to most European markets.
• It has also received all required approvals from German regulators for its medical cannabis products. Sales were temporarily suspended in December 2019. Existing sales orders will be filled from inventory held there.
IMO, it’s too hard to tell until they get the issues resolved which they appear to be working on.
Being illiquid or restricted like it is with select brokers allowing trading, don’t think we will truly know in the short term until it happens one way or the other.
For anyone looking for a pulse, there was an 8K posted today stating mike Ian’s one has retired as director.
I think you have a good shot, just need to be patient and think longer term!
Now holding 10k with just a few cents over a dollar avg. Hoping that these mystical term sheets come to fruition around earnings time, if not sooner. Got some other obligations to take care of but may pickup more if it keeps falling. Best of luck everyone.
Still thinking we see $5-10 this year, if not a BO in the fall.
Matt speaking at a panel discussion during WEF. Wonder if he can have some side meetings with potential investor groups/larger mining firms like Glencore to jumpstart this machine.
What’s the news? Nothing on google, OTC, nor EDGAR, unless my phone is lagging.
Thanks folks!
Ah yes, thank you for jogging my memory. I was on vacation and didn’t recall seeing that. I remember now.
Are you at liberty to share any feedback from your conversation(s)?
Assuming TC’s “term sheets” are indeed rolling in, and supposedly to be inked at JPM, which action Is most prudent vs most likely? Or same timing
Announcing a deal upon signing or at the next business update/earnings release?
I would think it’s most prudent to announce a partnership at inking rather than being most likely included with the next update. Lookin for other insight/reasoning.
Thanks in advance.
V for Vicinium
V for Victory
Yessir, as much as I hate to admit it, a portion of me still has hope in both of those and would be thrilled to see them succeed. OTC is just a learning experience.
In an unfortunate way, Im fortunate to have perpetual large gains on my company stock.
I’ve (hopefully) got years and years. Gonna prolly take the write offs though.
Any hope for vystar either? lol, Man two train wrecks.
This is almost unheard of......
Food for thought-
Are tutes getting leaked info somehow??
I’m optimistic/hopeful of a turnaround and overall bullish but wtf is pushing this up?
Obvious answer: The split pushed the price where tutes can buy and they were patient all this time.
Could this possibly slowly creep upwards till approx April when they expected BLA?
I don’t recall seeing any upcoming presentations.
Anyways- on a ski trip so not going to respond to many replies, may check in periodically.
Best wishes to everyone!
Sure hope it stays down until mid 1/2020 so I can double down and get my average back under a dollar!
I certainly agree. I don’t know why the SP is being held down. Can’t find a rational explanation about it, but seems like everything’s leaning mostly positively. I’m hoping for the best this coming year.
Yes RS shoulda kicked in today, right?
After reading articles about the Keytruda AdCom outcome, I’d say Vici has upwards of 90% chance of being recommended favorably for approval and is a virtual garuntee, IMO.
In addition, it almost makes too much sense for Merck to buy it outright.
I’ll be adding to my position after the first of the year.
Best of luck everyone!
Bill,
That’s my mistake. I went back and rechecked the June regulatory update and what I thought said “complete bla submission 1H 2020” was actually “OUS PARTNERSHIPS AS EARLY AS 1H 2020”. (To that point it could definitely be shortly after the turn of the new year as TC said term sheets were already coming in!)
I misrepresented what I recalled reading. Thanks for correcting my mistake.
And not that you referred to me, specifically, but I’m definitely not a shorter nor am I a basher. I’ve held my position and added to it since roughly the name and ticker change from EBIO to SESN when I found out about it. I do agree there are way too many shorters, but if that’s how they make their money, so be it. To each their own.
I’m definitely looking to hold this longer term and I definitely want to see it reach its potential later next year and into 2021 with a MC in the multi-billions.
Best of luck to you and everyone else.
I think the speculation for dilution, aside from the atm, is because they changed their wording on when BLA should be finished. Last update stated BLA submission 1H 2020 and the release yesterday pushed it back to 2H. They only have funds through “4Q 2020” also according to the release yesterday.
Wouldn’t put it past them to raise again before end of this coming year. But I do think the reaction yesterday was grossly exaggerated.
I agree with you. I have some disposable money.
Worst case- total loss and it’s a write off on a gain elsewhere.
Best case- average down.
Waiting for stabilization at or below penny level.
Dugie, I’m unfamiliar with that case but I’ll do some research.
Respectfully, I’m having trouble identifying your question, 2business.
Do I think the company has the intention to do as they say, sure. Do I wish them success, absolutely.
Time will tell. Monetarily speaking, I’d love for them to be successful and uplift without a RS. I love a small business growth story just like the next person.
Do I have hesitations regarding their acumen and experience to navigate the task at hand? Sure, but I’m willing to give them the benefit of the doubt.
I have decades (hopefully) to watch how this plays out.
Again, time will tell. If it happens, great. If it doesn’t, oh well. Lesson learned.
Yup, just chatter. But chatter isn’t silence. Time will tell.
I’m in no rush personally. Thought a position would keep me entertained. Basically a crapshoot. Only a small percentage to my overall portfolio.
GLTA.
New tweet:
“Now that the merger & related filings are complete, we are meeting with the investment bankers and will choose the right partner for Vystar on how to move forward with our plan to uplift. I know many are impatient for direction but we want to do this right the first time. $VYST”
I saw it through SeekingAlpha.
Although I haven’t had good luck with RS In the past, I largely agree with you Spidey.
We do have many events coming next year, some of them to trigger milestones. I think it’s strictly for listing and was most advised by the consulting firm.
I’m oddly optimistic.
The dreaded RS...
Everything is moving along swimmingly for sure... except the price, lol.
GL to you as well FullyBlown!
8KA should be available first thing in the morning.
8KA was accepted will be available to view about 6AM EST. A big thanks to everyone at Rotmans, accounting staff, & auditors for all the hard work over many months. It was a daunting, ambitious task bringing the Companies together and we now look forward to a bright future. $VYST pic.twitter.com/zRHIipHqpn
— Vystar Corporation (@VystarCompany) December 3, 2019
Another article out:
https://blackiron.com/black-iron-update-on-project-construction-financing/
Constructing likely to start by end of next year and lasting 24 months, but production about 2-3 years out. No worries. More time to load up more and more shares for the imminent explosion shortly thereafter.
If only it would let you buy at .0001, imagine!